Skip to main content

Market Overview

MercadoLibre, Applied Materials And A Healthcare Stock On CNBC's 'Final Trades'

Share:
MercadoLibre, Applied Materials And A Healthcare Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Jim Lebenthal at Cerity Partners named Applied Materials, Inc. (NASDAQ:AMAT) as his final trade.

Supporting his view, Cantor Fitzgerald analyst Matthew Prisco maintained an Overweight rating for Applied Materials on June 24, raising the price target from $200 to $220.

Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked UnitedHealth Group Incorporated (NYSE:UNH).

Lending support to his choice, JP Morgan analyst Lisa Gill maintained a UnitedHealth Group rating of Overweight on June 20 and raised the price target from $405 to $418.

Don't forget to check out our premarket coverage here

Joseph M. Terranova is a senior managing director for Virtus Investment Partners, named MercadoLibre, Inc. (NASDAQ:MELI) as his final trade.

Supporting his choice, Susquehanna analyst James Friedman, on June 26, maintained a Positive rating for MercadoLibre and raised the price target from $ 2,840 to $ 2,975.

Price Action:

  • Applied Materials shares fell 0.1% to close at $183.07 on Monday.
  • UnitedHealth Group rose 0.9% to settle at $311.97 during the session.
  • MercadoLibre shares gained 2.1% to settle at $2,613.63 on Monday.

Check This Out:

Photo: Shutterstock

 

Related Articles (AMAT + MELI)

View Comments and Join the Discussion!

Posted-In: CNBC Halftime Report Final Trades Jim LebenthalLong Ideas News Markets Media Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com